News
New research shows adults aged 35 to 64 prescribed gabapentin for chronic pain are twice as likely to develop dementia and ...
After a devastating diagnosis at just 61, the presenter and her husband have been documenting her life and the disease’s ...
The anti-seizure drug is used to treat epilepsy, nerve pain after shingles and restless legs syndrome by affecting chemical messengers in the brain and nerves.
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
AI users are spiraling into severe mental health crises after extensive use of chatbots like ChatGPT — and health experts are ...
Research shows that patients with six or more prescriptions for gabapentin, commonly used to treat lower back pain, were 29% more likely to be diagnosed with dementia and 85% more likely to be ...
Objectives The association between smoking and patients with schizophrenia has been established through epidemiological ...
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks ...
The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chro ...
As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...
As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...
2d
Investor's Business Daily on MSNAcadia Emerges From Behind The Scenes With A Potential $12 Billion OpportunityAcadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results